Home › Trial NCT07690878
PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer
- Trial IDNCT07690878
- StatusNot Yet Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Enrollment35
- Start date2026-07
- ConditionsBladder Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.